Arena Pharma (ARNA) Reports Complete Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis; Provides Program Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to Arena Pharma (ARNA) Reports Complete Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis; Provides Program Updates

Arena Pharma (ARNA) Prices 5.5M Share Common Offering at $50/Sh

May 28, 2020 8:32 AM EDT

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $50.00 per share. All of the shares are being sold by Arena. The gross proceeds from the offering... More

Arena Pharma (ARNA) PT Raised to $69 at Jefferies

May 22, 2020 5:12 AM EDT

Jefferies analyst Chris Howerton raised the price target on Arena Pharma (NASDAQ: ARNA) to $69.00 (from $62.00) while maintaining a Buy rating.... More